Show item record

dc.contributor.authorMorin, Mélanie
dc.contributor.authorDumoulin, Chantale
dc.contributor.authorBergeron, Sophie
dc.contributor.authorMayrand, Marie-Hélène
dc.contributor.authorKhalifé, Samir
dc.contributor.authorWaddell, Guy
dc.contributor.authorDubois, Marie-France
dc.contributor.authorProvoked vestibulodynia (PVD) Study Group
dc.date.accessioned2017-09-26T18:28:07Z
dc.date.availableMONTHS_WITHHELD:12fr
dc.date.available2017-09-26T18:28:07Z
dc.date.issued2016-01-30
dc.identifier.urihttp://hdl.handle.net/1866/19227
dc.subjectDyspareuniafr
dc.subjectLidocainefr
dc.subjectPelvic floor musclesfr
dc.subjectPhysical therapyfr
dc.subjectProvoked vulvodyniafr
dc.titleRandomized clinical trial of multimodal physiotherapy treatment compared to overnight lidocaine ointment in women with provoked vestibulodynia: Design and methodsfr
dc.typeArticlefr
dc.contributor.affiliationUniversité de Montréal. Faculté de médecine. École de réadaptationfr
UdeM.statutProfesseur(e) / Professorfr
dc.identifier.doi10.1016/j.cct.2015.11.013
dcterms.abstractProvoked vestibulodynia (PVD) is a highly prevalent and debilitating condition yet its management relies mainly on non-empirically validated interventions. Among the many causes of PVD, there is growing evidence that pelvic floor muscle (PFM) dysfunctions play an important role in its pathophysiology. Multimodal physiotherapy, which addresses these dysfunctions, is judged by experts to be highly effective and is recommended as a firstline treatment. However, the effectiveness of this promising intervention has been evaluated through only two small uncontrolled trials. The proposed bi-center, single-blind, parallel group, randomized controlled trial (RCT) aims to evaluate the efficacy of multimodal physiotherapy and compare it to a frequently used first-line treatment, topical overnight application of lidocaine, in women with PVD. A total of 212 women diagnosed with PVD according to a standardized protocol were eligible for the study and were randomly assigned to either multimodal physiotherapy or lidocaine treatment for 10weeks. The primary outcome measure is pain during intercourse (assessed with a numerical rating scale). Secondary measures include sexual function, pain quality, psychological factors (including pain catastrophizing, anxiety, depression and fear of pain), PFM morphology and function, and patients' global impression of change. Assessments are made at baseline, post-treatment and at the 6-month follow-up. This manuscript presents and discusses the rationale, design and methodology of the first RCT investigating physiotherapy in comparison to a commonly prescribed first-line treatment, overnight topical lidocaine, for women with PVD.fr
dcterms.isPartOfurn:ISSN:1551-7144
dcterms.languageengfr
UdeM.VersionRioxxVersion acceptée / Accepted Manuscript
oaire.citationTitleContemporary clinical trials
oaire.citationVolume46
oaire.citationStartPage52
oaire.citationEndPage59


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show item record

This document disseminated on Papyrus is the exclusive property of the copyright holders and is protected by the Copyright Act (R.S.C. 1985, c. C-42). It may be used for fair dealing and non-commercial purposes, for private study or research, criticism and review as provided by law. For any other use, written authorization from the copyright holders is required.